187 related articles for article (PubMed ID: 27333156)
1. Eyes on New Product Development.
Novack GD
J Ocul Pharmacol Ther; 2016; 32(6):341-2. PubMed ID: 27333156
[No Abstract] [Full Text] [Related]
2. Eyes on new product development.
Novack GD
J Ocul Pharmacol Ther; 2013 Oct; 29(8):701. PubMed ID: 24073621
[No Abstract] [Full Text] [Related]
3. Eyes on New Product Development.
Novack GD
J Ocul Pharmacol Ther; 2016 Jun; 32(5):238-9. PubMed ID: 27171173
[No Abstract] [Full Text] [Related]
4. Eyes on New Product Development.
Novack GD
J Ocul Pharmacol Ther; 2016 Dec; 32(10):639. PubMed ID: 27875665
[No Abstract] [Full Text] [Related]
5. Eyes on New Product Development.
Novack GD
J Ocul Pharmacol Ther; 2016 Oct; 32(8):483. PubMed ID: 27583778
[No Abstract] [Full Text] [Related]
6. Eyes on New Product Development.
Novack GD
J Ocul Pharmacol Ther; 2016 May; 32(4):185. PubMed ID: 27058691
[No Abstract] [Full Text] [Related]
7. Eyes on New Product Development.
Novack GD
J Ocul Pharmacol Ther; 2017 Jun; 33(5):335-336. PubMed ID: 28441083
[No Abstract] [Full Text] [Related]
8. Eyes on New Product Development.
Novack GD
J Ocul Pharmacol Ther; 2017 Mar; 33(2):65. PubMed ID: 28099041
[No Abstract] [Full Text] [Related]
9. Eyes on New Product Development.
Novack GD
J Ocul Pharmacol Ther; 2016 Nov; 32(9):563-564. PubMed ID: 27754810
[No Abstract] [Full Text] [Related]
10. Eyes on new product development: ophthalmic drug delivery.
Novack GD
J Ocul Pharmacol Ther; 2013 Mar; 29(2):90-1. PubMed ID: 23485090
[No Abstract] [Full Text] [Related]
11. NO-naproxen (AstraZeneca).
Monck N
IDrugs; 2003 Jun; 6(6):593-9. PubMed ID: 12811683
[TBL] [Abstract][Full Text] [Related]
12. Eyes on new product development.
Novack GD
J Ocul Pharmacol Ther; 2014 Oct; 30(8):603-4. PubMed ID: 25280174
[No Abstract] [Full Text] [Related]
13. Eyes on new product development.
Novack GD
J Ocul Pharmacol Ther; 2013; 29(6):513-4. PubMed ID: 23841863
[No Abstract] [Full Text] [Related]
14. Eyes on new product development.
Novack GD
J Ocul Pharmacol Ther; 2014 Jun; 30(5):371-2. PubMed ID: 24897062
[No Abstract] [Full Text] [Related]
15. Association for research in vision and ophthalmology - 2009 annual meeting. Reducing disparities in eye disease and treatment: part 1.
Hodgkinson L
IDrugs; 2009 Jul; 12(7):413-5. PubMed ID: 19579158
[No Abstract] [Full Text] [Related]
16. Toxicology testing in drug discovery and development.
Dorato MA; Buckley LA
Curr Protoc Toxicol; 2007 Feb; Chapter 19():Unit19.1. PubMed ID: 23045141
[TBL] [Abstract][Full Text] [Related]
17. A need for speed: Signals in drug development.
Nat Med; 2012 Dec; 18(12):1730-1. PubMed ID: 23223053
[No Abstract] [Full Text] [Related]
18. Eyes on New Product Development.
Novack GD
J Ocul Pharmacol Ther; 2016 Mar; 32(2):65-6. PubMed ID: 26863523
[No Abstract] [Full Text] [Related]
19. MT 100.
Drugs R D; 2003; 4(1):57-8. PubMed ID: 12568640
[No Abstract] [Full Text] [Related]
20. Ophthalmic Drug Discovery and Development.
Gukasyan HJ; Hailu S; Karami TK
Pharm Res; 2019 Mar; 36(5):69. PubMed ID: 30887132
[No Abstract] [Full Text] [Related]
[Next] [New Search]
